Brian P Brennan1, Catherine Lee2, Jason A Elias3, Jesse M Crosby4, Brittany M Mathes4, Marie-Christine Andre5, Christina M Gironda4, Harrison G Pope6, Michael A Jenike3, Garrett M Fitzmaurice7, James I Hudson6. 1. Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA; Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. Electronic address: bbrennan@partners.org. 2. Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA. 3. Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. 4. Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA. 5. Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA; Psychology Department, Suffolk University, Boston, MA, USA. 6. Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA. 7. Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA; Laboratory for Psychiatric Biostatistics, McLean Hospital, Belmont, MA, USA.
Abstract
BACKGROUND: Intensive residential treatment (IRT) is effective for severe, treatment-resistant obsessive-compulsive disorder (OCD). We sought to characterize predictors and course of response to IRT. METHODS: Admission, monthly, and discharge data were collected on individuals receiving IRT. We examined the association between baseline characteristics and percent change in OCD symptoms as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) using linear regression. We compared baseline characteristics of IRT responders (≥35% reduction in Y-BOCS) versus non-responders, and of patients who did versus those who did not achieve wellness (Y-BOCS ≤ 12) using non-parametric tests. To examine the course of OCD severity over time, we used linear mixed-effects models with randomly varying intercepts and slopes. RESULTS: We evaluated 281 individuals admitted to an IRT program. Greater baseline Y-BOCS scores were associated with a significantly greater percent reduction in Y-BOCS scores (β = -1.49 ([95% confidence interval: -2.06 to -0.93]; P < .001)). IRT responders showed significantly greater baseline Y-BOCS scores than non-responders (mean (SD) 28 (5.2) vs. 25.6 (5.8); P = .003) and lower past-year alcohol use scores than non-responders (1.4 (1.9) vs. 2.1 (2.2); P = .01). Participants who achieved wellness displayed lower hoarding factor scores than those who did not (5 (4.6) vs. 9.53 (6.3); P = .03). OCD symptoms declined rapidly over the first month but more slowly over the remaining two months. CONCLUSIONS: Higher baseline OCD severity, lower past-year alcohol use, and fewer hoarding symptoms predicted better response to IRT. IRT yielded an initial rapid reduction in OCD symptoms, followed by a slower decline after the first month.
BACKGROUND: Intensive residential treatment (IRT) is effective for severe, treatment-resistant obsessive-compulsive disorder (OCD). We sought to characterize predictors and course of response to IRT. METHODS: Admission, monthly, and discharge data were collected on individuals receiving IRT. We examined the association between baseline characteristics and percent change in OCD symptoms as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) using linear regression. We compared baseline characteristics of IRT responders (≥35% reduction in Y-BOCS) versus non-responders, and of patients who did versus those who did not achieve wellness (Y-BOCS ≤ 12) using non-parametric tests. To examine the course of OCD severity over time, we used linear mixed-effects models with randomly varying intercepts and slopes. RESULTS: We evaluated 281 individuals admitted to an IRT program. Greater baseline Y-BOCS scores were associated with a significantly greater percent reduction in Y-BOCS scores (β = -1.49 ([95% confidence interval: -2.06 to -0.93]; P < .001)). IRT responders showed significantly greater baseline Y-BOCS scores than non-responders (mean (SD) 28 (5.2) vs. 25.6 (5.8); P = .003) and lower past-year alcohol use scores than non-responders (1.4 (1.9) vs. 2.1 (2.2); P = .01). Participants who achieved wellness displayed lower hoarding factor scores than those who did not (5 (4.6) vs. 9.53 (6.3); P = .03). OCD symptoms declined rapidly over the first month but more slowly over the remaining two months. CONCLUSIONS: Higher baseline OCD severity, lower past-year alcohol use, and fewer hoarding symptoms predicted better response to IRT. IRT yielded an initial rapid reduction in OCD symptoms, followed by a slower decline after the first month.
Authors: Eric A Storch; Michael J Larson; Nathan A Shapira; Herbert E Ward; Tanya K Murphy; Gary R Geffken; Holly Valerio; Wayne K Goodman Journal: Depress Anxiety Date: 2006 Impact factor: 6.505
Authors: Thröstur Björgvinsson; Chad T Wetterneck; Dana M Powell; Gregory S Chasson; Sarah A Webb; John Hart; Susan Heffelfinger; Renee Azzouz; Terri L Entricht; Joyce E Davidson; Melinda A Stanley Journal: J Psychiatr Pract Date: 2008-05 Impact factor: 1.325
Authors: Michael H Bloch; Angeli Landeros-Weisenberger; Maria C Rosario; Christopher Pittenger; James F Leckman Journal: Am J Psychiatry Date: 2008-10-15 Impact factor: 18.112
Authors: Matt G Kushner; Suck Won Kim; Christopher Donahue; Paul Thuras; David Adson; Michael Kotlyar; James McCabe; Jillian Peterson; Edna B Foa Journal: Biol Psychiatry Date: 2007-06-22 Impact factor: 13.382
Authors: Eric A Storch; Lisa J Merlo; Heather Lehmkuhl; Gary R Geffken; Marni Jacob; Emily Ricketts; Tanya K Murphy; Wayne K Goodman Journal: J Anxiety Disord Date: 2007-12-23
Authors: Sabine Wilhelm; Ulrike Buhlmann; David F Tolin; Suzanne A Meunier; Godfrey D Pearlson; Hannah E Reese; Paul Cannistraro; Michael A Jenike; Scott L Rauch Journal: Am J Psychiatry Date: 2008-02-01 Impact factor: 18.112
Authors: Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch Journal: Neuropsychopharmacology Date: 2015-02-09 Impact factor: 7.853
Authors: Srinivas Balachander; Aakash Bajaj; Nandita Hazari; Ajay Kumar; Nitin Anand; M Manjula; Paulomi M Sudhir; Anish V Cherian; Janardhanan C Narayanaswamy; T S Jaisoorya; Suresh Bada Math; Thennarasu Kandavel; Shyam Sundar Arumugham; Y C Janardhan Reddy Journal: Can J Psychiatry Date: 2020-05-26 Impact factor: 4.356
Authors: Brian P Brennan; J Eric Jensen; Christine Perriello; Harrison G Pope; Michael A Jenike; James I Hudson; Scott L Rauch; Marc J Kaufman Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2016-02-01
Authors: Christopher Pittenger; Brian P Brennan; Lorrin Koran; Carol A Mathews; Gerald Nestadt; Michele Pato; Katharine A Phillips; Carolyn I Rodriguez; H Blair Simpson; Petros Skapinakis; Dan J Stein; Eric A Storch Journal: Psychiatry Res Date: 2021-03-04 Impact factor: 11.225
Authors: Johanna A M du Mortier; Karin C P Remmerswaal; Neeltje M Batelaan; Henny A D Visser; Jos W R Twisk; Patricia van Oppen; Anton J L M van Balkom Journal: Front Psychiatry Date: 2021-04-12 Impact factor: 4.157